Table 2.
Clinical characteristics of the patients in the positive- and negative-catecholamine groups.
| Variable | Negative-Catecholamine Group (n = 69) | Positive-Catecholamine Group (n = 145) | p Value |
|---|---|---|---|
| Age, years (n = 214) | 47.91 ± 12.53 | 45.10 ± 13.09 | 0.138 |
| Female, % (n = 214) | 41(59.4) | 71(49.0) | 0.152 |
| Diabetes, % (n = 214) | 7(10.1) | 50(34.5) | <0.001 |
| Hypertension, % (n = 214) | 30(43.5) | 106(73.1) | <0.001 |
| BMI, kg/m2 (n = 214) | 24.63 ± 2.98 | 24.26 ± 3.40 | 0.439 |
| Metabolic parameters | |||
| Glucose, mmol/L (n = 214) | 4.9(4.6, 5.65) | 5.6(4.9, 6.75) | 0.001 |
| Total cholesterol, mmol/L (n = 211) | 4.38(3.96, 4.92) | 4.55(4.03, 5.34) | 0.103 |
| Triglyceride, mmol/L (n = 211) | 1.36(0.90, 1.86) | 1.23(0.76, 1.76) | 0.36 |
| LDL-c, mmol/L (n = 210) | 2.63 ± 0.74 | 2.81 ± 0.77 | 0.106 |
| Tumor characteristics (n = 214) | |||
| Adrenal PPGL, % | 24(34.8) | 97(66.9) | <0.001 |
| Extra-adrenal PPGL, % | 45(65.2) | 48(33.1) | <0.001 |
| Tumor diameter (cm) | 4.0(3.0, 6.0) | 5.5(4.5, 7.0) | <0.001 |
PPGL, pheochromocytoma and paraganglioma; BMI, body mass index; LDL-c, low-density lipoprotein cholesterol.